CANCER
1PMPyU0
1PMPyU0
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Bloodwise 11<br />
STRATEGIC REPORT<br />
HIDING FROM THE IMMUNE POLICE<br />
Many cells, such as white blood cells,<br />
patrol the body to seek out foreign<br />
invaders or rogue cells and flag them for<br />
destruction. To avoid this, cancer cells may<br />
send out ‘I’m friendly’ signals to make them invisible<br />
to the immune system. Scientists are developing ways<br />
to unveil this invisibility cloak to usher in a killer<br />
immune attack.<br />
Professor Francesco Dazzi at Kings College London<br />
has a £1 million programme to develop ways, using<br />
different facets of the immune system, to overcome<br />
this immune cloaking to unleash a killer response.<br />
These sorts of approaches have the potential to be<br />
truly personalised.<br />
We’re also supporting early stage clinical trials in<br />
Oxford and Southampton to test new modified immune<br />
proteins that stick to leukaemia or lymphoma cells and<br />
flag them to other killer white blood cells.<br />
THE HALLMARKS OF <strong>CANCER</strong><br />
IGNORING THE RED LIGHT<br />
Cells are constantly monitoring and<br />
receiving signals from the surrounding<br />
environment. The signals determine when new cells<br />
are needed and when growth should be stopped. These<br />
provide a counter-balance to the ‘go’ signals and make<br />
sure cells are put in sleep mode at the right times.<br />
Cancer cells acquire genetic faults that mean they are<br />
insensitive to growth-preventing signals from their<br />
neighbours that normally act as safety valves against<br />
uncontrolled cell growth.<br />
Dr Jonathan Strefford at the University of Southampton<br />
has a £250,000 project that will use cultured and<br />
isolated leukaemia cells to discover how faults in a key<br />
protein prevent chronic lymphocytic leukaemia (CLL)<br />
cells from being pushed to cell death by surrounding<br />
signals or drugs. This will help us better understand<br />
disease progression and to develop ways to overcome<br />
drug resistance.<br />
ENDLESS NEW CELLS<br />
Chromosomes – the packets of genetic<br />
material in our cells – have protective<br />
caps at their ends, like the plastic at the<br />
ends of shoelaces. As normal cells grow<br />
and divide, these protective caps get nibbled away.<br />
When they get too short, the cell enters sleep mode or<br />
activates its cell death program. This means normal<br />
cells have a finite limit on the number of divisions –<br />
another safety mechanism to prevent uncontrolled<br />
growth.<br />
Certain genetic faults, however, can cause overactivation<br />
of proteins that keep lengthening the<br />
protective caps, meaning they’re capable of limitless<br />
growth and division. The DNA in these immortal cells<br />
become more and more damaged over time, leading to<br />
cancer.<br />
When a protein called NF-kB switches on it triggers a<br />
cell to multiply. Faults in this protein can cause it to<br />
become permanently active, pushing the cell towards<br />
endless growth. Professor Guido Franzoso’s team<br />
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />
Registered charity 216032 (England & Wales) SC037529 (Scotland)